Sofinnova Investments, Inc.

Position in BMRN — Biomarin Pharmaceutical Inc

CIK 1631134 Menlo Park, CA

Position in BMRN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$20,517,260

-$23,656,903 QoQ

Shares Held

358,568

-54.1% QoQ

Ownership

0.185%

of shares outstanding

% of Portfolio

1.10%

of 13F equity value

Holder Rank

#78

of 564 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Sofinnova Investments, Inc. holds $1,182,454,857 across 43 Biotechnology names. BMRN ranks #20 (1.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VERA	Vera Therapeutics, Inc.	2,793,987	$119,889,982
2	GMAB	Genmab A/S	4,045,215	$111,122,056
3	JAZZ	Jazz Pharmaceuticals plc	365,341	$88,036,220
4	RAPP	Rapport Therapeutics, Inc.	1,904,408	$79,356,681
5	SPTX	Seaport Therapeutics, Inc.	3,564,871	$77,428,998
6	AVBP	ArriVent BioPharma, Inc.	1,696,752	$58,945,164
7	RARE	Ultragenyx Pharmaceutical Inc.	1,717,505	$57,347,491
8	RYTM	Rhythm Pharmaceuticals, Inc.	408,027	$45,303,237

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$20,517,260	358,568	-54.1%	Shares	Sole	2026-08-14
2026-03-31	$44,174,163	781,982	+12.2%	Shares	Sole	2026-05-15
2025-12-31	$41,430,614	697,133	+94.2%	Shares	Sole	2026-02-13
2023-03-31	$34,912,563	359,035	-9.0%	Shares	Sole	2023-05-11
2022-12-31	$40,841,604	394,643	+33.9%	Shares	Sole	2023-02-14
2022-09-30	$24,985,957	294,750	-2.3%	Shares	Sole	2022-11-08
2022-06-30	$24,994,006	301,605	+70.8%	Shares	Sole	2022-08-15
2022-03-31	$13,610,694	176,533	+102.2%	Shares	Sole	2022-05-16
2021-12-31	$7,714,898	87,322	-46.9%	Shares	Sole	2022-02-14
2020-12-31	$14,428,951	164,545	-36.4%	Shares	Sole	2021-02-16
2020-09-30	$19,678,320	258,653	+311.2%	Shares	Sole	2020-11-13
2020-06-30	$7,757,714	62,897	-73.8%	Shares	Sole	2020-08-13
2020-03-31	$20,283,886	240,046	—	Shares	Other	2020-05-13
No filing history on record for this holder in this stock.